Under the revised structure, Natco Pharma (Canada) Inc will invest $13.70 million, while Natco Pharma USA LLC will contribute $3 million, according to a regulatory filing
The post Natco Pharma hikes investment in US-based eGenesis to $16.7 million appeared first on Home Page.
